Last updated on June 2019

A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome


Brief description of study

This is a two-part, multicenter, double-blind, parallel-group, placebo controlled study to evaluate the effect of ZX008 when used as adjunctive therapy for the treatment of uncontrolled seizures in children and adults with Lennox-Gastaut syndrome (LGS).

Clinical Study Identifier: NCT03355209

Find a site near you

Start Over

Center for Neurosciences

Tucson, AZ United States
  Connect »

Florida Hospital Orlando

Orlando, FL United States
  Connect »

Pediatric Neurology, PA

Orlando, FL United States
  Connect »

Spectrum Health

Grand Rapids, MI United States
  Connect »

William Beaumont Hospital

Royal Oak, MI United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

Minnesota Epilepsy Group, PA

Saint Paul, MN United States
  Connect »

University Hospital Cleveland

Cleveland, OH United States
  Connect »

Wellspan Pediatric Neurology

Manchester, PA United States
  Connect »

Baylor College of Medicine

San Antonio, TX United States
  Connect »

University of Utah

Salt Lake City, UT United States
  Connect »

Seattle Children's Hospital

Seattle, WA United States
  Connect »

Sick Kids

Toronto, ON Canada
  Connect »

NZOZ Vitamed

Bydgoszcz, Poland
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.